Forward Therapeutics
Forward Therapeutics: Innovating chronic inflammatory treatment through advanced oral immune therapies.
Forward Therapeutics: Innovating chronic inflammatory treatment through advanced oral immune therapies.
Forward Therapeutics, a biopharmaceutical company, is dedicated to transforming the treatment of chronic inflammatory disorders through advanced oral immune therapies. The company's core mission is to develop next-generation small molecule therapies that can significantly improve patient care. Their market focus is on delivering blockbuster oral agents that target validated immunology pathways, aiming to provide effective and convenient treatment options for patients suffering from chronic inflammatory conditions.
Notable figures associated with Forward Therapeutics include leading scientific experts in immunology and drug development. The company has achieved significant milestones in its integrated discovery and development processes, leveraging cutting-edge capabilities to advance its pipeline. Forward Therapeutics' impact lies in its potential to revolutionize patient care by offering innovative oral therapies that address unmet medical needs in chronic inflammation.
Companies similar to Forward Therapeutics include SFA Therapeutics, Rise Therapeutics, i2o Therapeutics and Invea Therapeutics.
Forward Therapeutics was founded in 2022.
Forward Therapeutics' headquarters is located in Palm Beach Gardens, FL, US.
Forward Therapeutics' most recent funding round was for $50M (USD) in November 2023.
As of Nov 8, 2023, Forward Therapeutics has disclosed funding of $50M (USD). Undisclosed round amounts are excluded.
Forward Therapeutics has 2 employees as of Feb 4, 2024.
Invea Therapeutics
inveatx.com
